HMGB1 and bronchiolitis: Significantly, the inhibition of MLKL or RIPK1 decreased RSV-induced hAEC cell death and associated HMGB1 release in vitro, and conferred protection against severe bronchiolitis in vivo in a preclinical model (Simpson et al., 2020).